Novel Therapy of Heterogeneous B-cell Acute Lymphocytic Leukemia by Targeting Convergent Oncogenic Mediators STATs |
University of Alberta / Hasan Uludag, PhD |
Innovation Grants |
2019 |
Alberta |
Saturating CRISPR gene body scans in MLL-rearranged leukemia |
Beckman Research Institute of City of Hope / Chun-Wei Chen, PhD |
Innovation Grants |
2019 |
California |
The use of hematopoietic stem and progenitor cells to reverse treatment resistance to PD-1 blockade |
University of Florida / Catherine Flores, PhD |
Innovation Grants |
2019 |
Florida |
Targeting mechanisms of Siglec15-mediated immune evasion in hematologic malignancies |
Emory University / Christopher Porter, MD |
Innovation Grants |
2019 |
Georgia |
The anti-tumor immune microenvironment in the Sonic Hedgehog subclass of medulloblastoma |
Emory University / Anna Kenney, PhD |
Innovation Grants |
2019 |
Georgia |
Predicting and Overcoming Resistance to Immunotherapy in Pediatric High-Grade Glioma |
Ann & Robert H. Lurie Children’s Hospital of Chicago / Oren Becher, MD & Robert Wechsler-Reya, PhD |
Innovation Grants |
2019 |
Illinois |
Targeting symmetric division in pediatric cancers |
Dana-Farber Cancer Institute / Rosalind Segal, MD/PhD |
Innovation Grants |
2019 |
Massachusetts |
Selectively targeting EP300 with small molecules for neuroblastoma (NB) therapy |
Dana-Farber Cancer Institute / Jun Qi, PhD |
Innovation Grants |
2019 |
Massachusetts |
Epigenetic regulation of genomic instability and its therapeutic implications in T-cell acute lymphoblastic leukemia |
Dana-Farber Cancer Institute / Birgit Knoechel, MD/PhD |
Innovation Grants |
2019 |
Massachusetts |
Therapeutic Targeting of the Disrupted Metabolic State in DIPG |
University of Michigan / Costas Lyssiotis, PhD & Sriram Venneti, MD/PhD |
Innovation Grants |
2019 |
Michigan |